AcuCort AB (publ) (XSAT:ACUC)
Sweden · Delayed Price · Currency is SEK 0.6380
-0.0020 (-0.31%)
At close: Jul 13, 2026
AcuCort AB Company Description
AcuCort AB (publ), a pharmaceutical company, identifies, develops, and commercializes drugs in Sweden.
The company offers Zeqmelit, a dissolving, thin, and small oral film containing the glucocorticoid dexamethasone for the treatment of severe and acute allergic reactions, asthma, croup in children, nausea and vomiting associated with chemotherapy, and patients with COVID-19 with breathing difficulties and require oxygen therapy.
AcuCort AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
AcuCort AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 5 |
| CEO | Jonas Jonmark |
Contact Details
Address: Medicon Village Lund, 223 81 Sweden | |
| Phone | 46 4 65 90 09 90 |
| Website | acucort.se |
Stock Details
| Ticker Symbol | ACUC |
| Exchange | Spotlight Stock Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jonas Jonmark | Chief Executive Officer |